Search Results
May 14, 2025, 10:22 ET North Castle Partners' Prestigious "CEO Of The Year" Award To Tony Scrimale, Top Crunch Fitness Franchisee
partner of CR Fitness Holdings LLC, the top franchisee for Crunch Fitness, has recognized CEO Tony Scrimale as the recipient of their 2025 "CEO of the Year" award. A tradition now in its 25th year, this marks the second time in the past four years CR Fitness Holdings
More news about: CR Fitness Holdings, LLC.
May 14, 2025, 09:00 ET SK chemicals Strengthens Position in Cosmetics Packaging with Circular Materials at China Beauty Expo
for high-end applications where crystal-clear presentation is essential. CLARO-CR70, the aforementioned high-performance circular copolyester material introduced last year, contains up to 70% PCR content. CLARO CR70 uses recycled plastic as a raw material and can be recycled after use, making
More news about: SK chemicals
May 14, 2025, 09:00 ET SK chemicals Signs MOU with Malaysia's Leading Kitchenware Manufacturer LH Plus - "Accelerates Expansion into Southeast Asian Market with Sustainable Materials"
containing biomass—and SKYPET CR—a circular recycled PET made from waste plastics—by 2027. The 2,000 tons of raw materials can produce approximately 100 million 1-liter water bottles. The two companies will also collaborate on developing new kitchenware products using ECOZEN and SKYPET CR materials and expanding
More news about: SK chemicals
May 14, 2025, 08:00 ET ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
glofitamab (COLUMVI®) demonstrated an overall response rate (ORR) of 95.5% and complete response (CR) rate of 90.9%. Four of the efficacy evaluable patients (2 each at 120µg/kg and 150 µg/kg) converted to CR within 3 weeks after the data cutoff and are included as CRs. Twenty of 21 responders have remained
More news about: ADC Therapeutics SA
May 14, 2025, 07:45 ET ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML)
ZYNLONTA® plus glofitamab (COLUMVI®) demonstrated ORR of 95.5% and CR of 90.9%, among 22 evaluable patients with relapsed/refractory DLBCL Safety and tolerability data were consistent with the known profiles
More news about: ADC Therapeutics SA
May 14, 2025, 07:00 ET Grand Boulevard Names Jenny Taylor As General Manager
operations at the 52-acre mixed-use property, founded in 2003 and located in the heart of the Walton County, just off iconic CR 30A, and between Pensacola and Panama City. Grand Boulevard has more than 775,000 square
More news about: Grand Boulevard at Sandestin
May 14, 2025, 06:56 ET China's Retail Revolution: 2025CHINASHOP Sets Stage for Industry Transformation in Shenzhen
CHINASHOP hosted its inaugural Consumer Goods Channel Selection Conference, where China's top retailers like CR Vanguard, Rainbow, and JD Supermarket announced their procurement needs on site. Over 100 retailers engaged in one-on-one matchmaking sessions, accelerating
More news about: CHINASHOP
May 14, 2025, 04:00 ET SK chemicals Strengthens Position in Cosmetics Packaging with Circular Materials at China Beauty Expo
for high-end applications where crystal-clear presentation is essential. CLARO-CR70, the aforementioned high-performance circular copolyester material introduced last year, contains up to 70% PCR content. CLARO CR70 uses recycled plastic as a raw material and can be recycled after use, making
More news about: SK chemicals
May 14, 2025, 04:00 ET SK chemicals fortalece su posición con materiales circulares en China Beauty Expo
aplicaciones de alta gama donde una presentación impecable es esencial. CLARO-CR70, el material de copoliéster circular de alto rendimiento ya mencionado, presentado el año pasado, contiene hasta un 70 % de PCR. CLARO CR70 utiliza plástico reciclado como materia prima y puede reciclarse tras su uso,
More news about: SK chemicals
May 14, 2025, 01:38 ET Caliway Announces Successful EOP2 Meeting with the FDA for CBL-514 in Reduction of Abdominal Subcutaneous Fat
relevant regulations, including the FDA's guideline on Patient-Focused Drug Development. The Clinician Reported-AFRS (CR-AFRS) and the Patient Reported-AFRS (PR-AFRS) are used to assess treatment response based on the physician's
More news about: Caliway Biopharmaceuticals
May 14, 2025, 00:51 ET SK chemicals、中国美容博覧会にてサーキュラーマテリアルを活用した化粧品包装分野での地位を強化
これらの材料は、さまざまな容器形式に適合するだけでなく、高性能コポリエステルベースにより、高級化粧品パッケージに必要な機械的強度と美的品質も提供します。 PETやコポリエステルといった従来の汎用プラスチックと比較しても、厚肉容器においても透明性が高く、クリスタルクリアな外観が求められる高級用途に最適です。 前述のCLARO-CR70は、昨年発売された高性能なコポリエステル材料で、最大70％のPCR含有率を実現しています。CLARO CR70は再生プラスチックを原料とし、閉ループのプラスチックリサイクルシステム構築にも適しています。 同展示会では、SKYPET CR（大容量ボディケア用円形PET素材）や、植物由来成分およびバイオエタノール由来のポリオールから製造された100％バイオベース素材ECOTRIONなど、他の持続可能素材も紹介されました。
More news about: SK chemicals
May 13, 2025, 23:50 ET 康霈CBL-514順利完成FDA EOP2會議
AFRS為康霈依照美國FDA建議與Patient-Reported Outcome Measures相關法規要求所開發並完成確效的一項1到5級的腹部皮下脂肪堆積評量表，並已經過FDA書面審查。等級分數越高代表腹部皮下脂肪堆積越嚴重，不同等級在臨床上具有顯著差異。Clinician Reported (CR-AFRS)表示由試驗醫師評估受試者之腹部皮下脂肪堆積等級；Patient Reported (PR-AFRS)則表示由受試者自評之腹部皮下脂肪堆積等級。 *關於康霈康霈生技股份有限公司於101年創立，致力於開發能超越現有療法，改變市場創新的新藥產品，將台灣充沛的新藥研發量能發揮於全球生醫與醫美產業，已於113年10月2日正式掛牌上市。
More news about: 康霈生技
May 13, 2025, 10:45 ET Smart Robots Market worth $135.83 billion by 2034 - Exclusive Report by The Research Insights
high-payload capacity collaborative robots at the Automate 2023 show. The CRX and CR collaborative robot lines introduce models designed to handle weight capacities from 4 kg up to 50 kg. The CRX-25iA cobot with a 30 kg capacity and the CR-35iB cobot with a 50 kg capacity were showcased during the demonstrations. FANUC
More news about: The Research Insights
May 13, 2025, 08:00 ET Kelley Blue Book Names 12 Best Family Cars of 2025
12 Best Family Cars: Kelley Blue Book's 12 Best Family Cars of 2025 Best 2-Row SUVs for Families2025 Honda CR-V2025 Hyundai Ioniq 52025 Subaru Outback Best 3-Row Vehicles for Families2025 Chevrolet Tahoe2025 Ford
More news about: Kelley Blue Book
May 13, 2025, 03:52 ET Happiest Minds accelerates to 31% growth in Q4, reports revenues of ₹545 Crores driven by strong deal closures
Robust annual EBITDA of ₹462 Cr at 21.4% margin, reflecting consistent operating profitability BENGALURU, India and SEATTLE and LONDON,
More news about: Happiest Minds Technologies Limited
May 13, 2025, 02:25 ET Star Health Announces New Board Appointments
and 17,000 employees. In FY25, Star Health's gross written premium stood at Rs.17,553 Cr with its net worth at Rs.8,668 Cr. For more information, visit www.starhealth.in
More news about: Star Health and Allied Insurance
May 11, 2025, 20:00 ET CARsgen Announces Preliminary Clinical Data for Allogeneic BCMA CAR-T CT0596, Demonstrating Favorable Safety and Efficacy
events.1) Among 5 patients who completed the first efficacy assessment at Week 4, 3 patients (60%) achieved stringent complete response/complete response (sCR/CR), and 4 patients (80%) achieved minimal residual disease (MRD)-negativity in the bone marrow. 2) Early efficacy data from 2 patients at Day 14 showed
More news about: CARsgen Therapeutics
May 09, 2025, 08:22 ET DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase Program
https://www.accessdata.fda.gov/scrIpts/cdrh/cfdocs/cfrl/rl.cfm?start_search=1&establishmentName=®Num=&StateName=&CountryName=CR&RegistrationNumber=&OwnerOperatorNumber=&OwnerOperatorName=&ProductCode=&DeviceName=&ProprietaryName=&establishmentType=5&pagenum=100
More news about: DOMA Perpetual
May 08, 2025, 22:00 ET PEC Ltd. का Liberty Energy Solutions Ltd. द्वारा US$160 मिलियन में अधिग्रहण और निजीकरण
www.shawkwei.com पर जाएं। CR3 प्राइवेट लिमिटेड का परिचय: सिंगापुर में 1991 में स्थापित, CR3 सिंगापुर, थाईलैंड, भारत, मलेशिया और UAE में परिचालन केंद्रों से 18 एशियाई देशों, भारत और मध्य-पूर्व में ऊर्जा इंजीनियरिंग समाधान प्रदान करती है। CR3 ऊर्जा उत्पादन, रासायनिक प्रोसेसिंग
More news about: Liberty Energy Solutions Ltd; ShawKwei & Partners
May 08, 2025, 20:30 ET Akuisisi dan privatisasi Liberty Energy Solutions Ltd bernilai US$ 160 juta oleh PEC Ltd.
terkemuka di dunia, termasuk ExxonMobil, Reliance, SPRC, Neste, Chevron, Nayara, Petronas, BP, dan Shell. Liberty Energy menaungi dua anak usaha: CR3 Pte Ltd ("CR3"), pemimpin pasar solusi efisiensi energi, teknik, dan pembangunan berkelanjutan di Singapura, serta ZymeFlow LLC ("ZymeFlow"), pemimpin pasar
More news about: Liberty Energy Solutions Ltd; ShawKwei & Partners
May 08, 2025, 16:05 ET Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights
mg QD (Cohort 2). Following a review of efficacy and safety, an additional dosing cohort may be evaluated. The primary endpoint is complete response (CR) rate at three months. Secondary endpoints include time to recurrence, the median duration of response, recurrence free survival (RFS), progression free
More news about: Tyra Biosciences
May 08, 2025, 10:20 ET Aarti Industries Delivers Volume-Led Growth in Q4; Sets Strong Foundation for FY26 with Strategic Expansions and Sustainability Focus
consolidated basis, for the quarter, income from operations stood at ₹ 2214 Cr, compared to ₹ 2038 Cr in Q3 FY25 ('previous quarter'). EBITDA stood at ₹ 266 Cr, compared to ₹ 236 Cr in the previous quarter. PAT stood at ₹ 96 Cr, compared to ₹ 46 Cr in the previous quarter. FY25-26 has commenced on a confident
More news about: Aarti Industries
May 06, 2025, 21:00 ET PEC Ltd. US$160 million buyout and privatization by Liberty Energy Solutions Ltd
ExxonMobil, Reliance, SPRC, Neste, Chevron, Nayara, Petronas, BP, and Shell. Liberty Energy is the parent of two wholly owned subsidiaries: CR3 Pte Ltd ("CR3"), a Singapore-based leader in energy efficiency, engineering excellence, and sustainable solutions, and ZymeFlow
More news about: Liberty Energy Solutions Ltd; ShawKwei & Partners
May 06, 2025, 21:00 ET PEC Ltd. US$160 million buyout and privatization by Liberty Energy Solutions Ltd
ExxonMobil, Reliance, SPRC, Neste, Chevron, Nayara, Petronas, BP, and Shell. Liberty Energy is the parent of two wholly owned subsidiaries: CR3 Pte Ltd ("CR3"), a Singapore-based leader in energy efficiency, engineering excellence, and sustainable solutions, and ZymeFlow
More news about: Liberty Energy Solutions Ltd; ShawKwei & Partners
May 06, 2025, 20:00 ET 雙靶頭對頭：信達生物全球首創抗VEGF-補體雙靶融合蛋白依莫芙普（IBI302）治療糖尿病黃斑水腫的II期臨床研究完成首例受試者給藥
美國舊金山和中國蘇州2025年5月7日 /美通社/ -- 信達生物製藥集團（香港聯交所股票代碼：01801），一家致力於研發、生產和銷售腫瘤、自身免疫、代謝及心血管、眼科等重大疾病領域創新藥物的生物製藥公司，近日宣布其研發的重組人血管內皮生長因子受體（VEGFR）和人補體受體1（CR1）融合蛋白依莫芙普注射液（研發代號：IBI302）的一項II期臨床研究完成首例受試者給藥。 本研究是一項在糖尿病黃斑水腫（DME）受試者中進行的隨機、雙盲、多中心、活性對照的II期臨床研究（NCT06908876），旨在評估玻璃體腔注射IBI302在DME受試者中的療效和安全性。本試驗計劃入組150例受試者，按1:1:1比例隨機分配至IBI302
More news about: 信達生物